Drawing for CELLTECH PHARMACEUTICALS

USPTO serial 76329413

CELLTECH PHARMACEUTICALS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MCMORROW, RONALD G
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CELLTECH PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVENEW YORK, NY 10017-5621UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and gene therapy products, namely, allergy medications, analgesics, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, anticoagulants, antidepressants, antihistamines, bronchodilators, cardiovascular pharmaceuticals, clinical medical reagents, decongestant tablets, expectorants, hemoglobin, hormones, hydrocortisone, medicated lozenges, migraine treatment preparations muscle relaxants, nasal spray preparations, nausea treatment preparations, pain relief medication, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparation for use in chemotherapy, vaccines; ant-convulsants; gastrointestinal medications; pharmaceutical preparations for the treatment of bone disorders, central nervous system disorders or shock; cough treatment preparationsACTIVE—
010Inhalers for therapeutic use, sold filled with a pharmaceutical preparationACTIVE—
042Research in the fields of biological, medical and chemical sciences and consultation related thereto, product research and development in the fields of biological, medical and chemical sciencesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 14, 2008MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 14, 2008ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 14, 2007CNSIINQUIRY AS TO SUSPENSION MAILED—
Dec 13, 2007CNSISUSPENSION INQUIRY WRITTEN—
Dec 6, 2007RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 6, 2007ALIEASSIGNED TO LIE—
Jun 4, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 30, 2006RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 8, 2006CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 10, 2006MAILPAPER RECEIVED—
May 25, 2006RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 8, 2006CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 7, 2006MAILPAPER RECEIVED—
Nov 22, 2005RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 16, 2005RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 1, 2004RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 21, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 21, 2003CFITCASE FILE IN TICRS—
Jan 17, 2003CNSLLETTER OF SUSPENSION MAILED—
Nov 20, 20021.BDSec. 1(B) CLAIM DELETED—
Nov 20, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 20, 2002MAILPAPER RECEIVED—
Aug 21, 2002CNSLLETTER OF SUSPENSION MAILED—
Jul 12, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2002MAILPAPER RECEIVED—
Jan 11, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance